The translation of pre-clinical results into therapies will be an important aspect of stem cell research over the next ten years
Durham, NC & Seoul, Korea (Vocus) November 11, 2010
The journal STEM CELLS has announced Dr. Cinzia Rota as the winner of the annual STEM CELLS Young Investigator Award. Co-sponsored by the International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in STEM CELLS and judged to be most important by the Journal editors.
Dr. Rota, from the Mario Negri Institute for Pharmacological Research in Bergamo, Italy, was awarded the prize for her paper entitled ‘Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury.’
“The translation of pre-clinical results into therapies will be an important aspect of stem cell research over the next ten years” said Rota. “Students entering this field should know that it is fascinating, with the opportunity to produce results that can potentially be translated in clinical practice, providing hope in areas where traditional medicine does not offer therapeutic opportunities.”
Dr. Rota’s award winning paper investigated the potential of human cord blood to cure acute kidney injury. The research revealed the potential for of human cord-blood stem cells as a future cell therapy.
“I think that one of the most important things for the public to understand is the different characteristics and regenerative potentials of human embryonic and adult stem cells; that these cells are not interchangeable, and that one or the other may be better for certain clinical applications,” said Rota. “Therefore, detailed studies on ESCs, iPS cells, and adult stem cell are all necessary to provide for future cell therapy applications.”
The award was announced at the annual International Stem Cell Symposium, hosted at the Catholic University of Korea in Seoul.
“Stem cell science is one of the most attractive fields for those who are interested in fundamental basic science as well as its clinical application. Ambitious young scientists are absolutely welcome in this exciting field,” said Professor Il-Hoan Oh, Director of The Catholic University of Korea’s Cell & Gene Therapy Institute and chair of the Symposium’s organizing committee. “We need to remember that ultimately we are working to advance stem cell science to help people and our society.”
The winning paper is published in STEM CELLS. Media Wishing to request a copy should contact Lifesciencenews(at)wiley(dot)com or phone +44 (0)1243 770 375
Morigi. M, Rota. C, Montemurro. T, Montelatici. E, Lo Cicero. V, Imberti. B, Abbate. M, Zoja. C, Cassis. P, Longaretti. C, Rebulla. P, Introna. M, Capelli. C, Benigni. A, Remuzzi. G, Lazzari. L, “Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury,” STEM CELLS, Wiley-Blackwell, January 2010, DOI: 10.1002/stem.293
About the International Stem Cell Symposium
The International Stem Cell Symposium has been organized annually by faculty of The Catholic University of Korea at which the most promising basic and clinical research dealing with stem cells and their therapeutic applications is critically discussed by cutting-edge Asia-Pacific researchers. The non-profit Symposium’s mission is to foster “ethical stem cell research to help intractably ill patients.”
About STEM CELLS: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research.
For more information, please visit: http://bit.ly/b4I7DN
STEM CELLS is co-published by AlphaMed Press and Wiley-Blackwell.
About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC and Belfast, United Kingdom publishes two internationally renowned peer-reviewed journals: STEM CELLS®, now in its 28th year, is the world's first journal devoted to this fast paced field of research. The Oncologist® (http://www.TheOncologist.com), also a monthly peer-reviewed publication, is in its 15th year and is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. Both journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. AlphaMed Press publishes the Stem Cells Portal online (http://www.StemCellsPortal.com), as well as freestanding monographs and books, and is renowned for its excellence and speed in the publication of the peer-reviewed proceedings of major international symposia. For more information on AlphaMed Press, please visit http://www.alphamedpress.org.
Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit http://www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world’s most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.